Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Mar 20  •  04:00PM ET
23.98
Dollar change
-1.14
Percentage change
-4.54
%
Mar 17, 12:01 PMManagement's positive fireside chat at KeyBanc Healthcare Forum ignited 6.76% intraday surge.
Index- P/E- EPS (ttm)-0.47 Insider Own0.92% Shs Outstand496.98M Perf Week4.53%
Market Cap11.92B Forward P/E20.51 EPS next Y1.17 Insider Trans0.96% Shs Float492.58M Perf Month-4.84%
Enterprise Value15.52B PEG1.68 EPS next Q0.34 Inst Own108.90% Short Float3.06% Perf Quarter8.61%
Income-232.00M P/S2.53 EPS this Y9.78% Inst Trans-6.28% Short Ratio3.13 Perf Half Y25.55%
Sales4.71B P/B1.82 EPS next Y13.30% ROA-1.79% Short Interest15.07M Perf YTD5.97%
Book/sh13.17 P/C21.88 EPS next 5Y12.19% ROE-3.67% 52W High27.72 -13.49% Perf Year126.65%
Cash/sh1.10 P/FCF41.98 EPS past 3/5Y-43.04% 18.11% ROIC-2.19% 52W Low8.02 199.00% Perf 3Y157.30%
Dividend Est.- EV/EBITDA16.65 Sales past 3/5Y2.25% 7.57% Gross Margin43.48% Volatility4.85% 4.15% Perf 5Y-22.87%
Dividend TTM- EV/Sales3.29 EPS Y/Y TTM-168.20% Oper. Margin5.34% ATR (14)1.00 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.08 Sales Y/Y TTM6.22% Profit Margin-4.92% RSI (14)47.10 Recom1.41
Dividend Gr. 3/5Y- - Current Ratio2.17 EPS Q/Q-3328.40% SMA20-2.61% Beta1.87 Target Price29.46
Payout0.00% Debt/Eq0.63 Sales Q/Q12.16% SMA50-2.44% Rel Volume1.93 Prev Close25.12
Employees9900 LT Debt/Eq0.62 EarningsFeb 24 BMO SMA20018.85% Avg Volume4.82M Price23.98
IPOSep 20, 2018 Option/ShortYes / Yes EPS/Sales Surpr.14.54% 4.67% Trades Volume9,322,537 Change-4.54%
Date Action Analyst Rating Change Price Target Change
Jan-22-26Upgrade Piper Sandler Neutral → Overweight
Dec-09-25Initiated Barclays Overweight $30
Nov-21-25Initiated KeyBanc Capital Markets Overweight $27
Nov-19-25Upgrade Argus Hold → Buy $25
Oct-07-25Upgrade JP Morgan Neutral → Overweight $24
Jul-17-25Upgrade Leerink Partners Market Perform → Outperform $18
Jun-26-25Upgrade William Blair Mkt Perform → Outperform
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Sep-19-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $15
Mar-16-26 03:23PM
Feb-26-26 09:56AM
Feb-24-26 04:22PM
03:08PM
02:01PM
12:32PM Loading…
12:32PM
11:25AM
09:30AM
08:15AM
06:38AM
06:27AM
Feb-23-26 10:57AM
Feb-22-26 10:06PM
Feb-19-26 09:15AM
08:00AM
09:24AM Loading…
Feb-13-26 09:24AM
Feb-10-26 06:41AM
Jan-30-26 11:56AM
Jan-28-26 07:50AM
Jan-27-26 04:04PM
Jan-26-26 11:35PM
Jan-22-26 04:36PM
08:00AM
06:00AM
Jan-12-26 06:54PM
Jan-06-26 11:08PM
06:52PM
08:00AM
Dec-31-25 02:00PM
Dec-21-25 10:07AM
01:30AM Loading…
Dec-19-25 01:30AM
Dec-18-25 08:43AM
Dec-16-25 02:05PM
09:40AM
Dec-12-25 12:00PM
Dec-09-25 04:15PM
07:40AM
Nov-24-25 07:00PM
Nov-21-25 01:35PM
Nov-20-25 08:00AM
Nov-14-25 09:03AM
Nov-13-25 08:00AM
Nov-12-25 12:35AM
Nov-11-25 08:46AM
Nov-06-25 12:33AM
Nov-05-25 07:26PM
03:12PM
02:01PM
09:30AM
07:35AM
06:36AM
06:27AM
Nov-03-25 10:19PM
04:28PM
Oct-29-25 10:00AM
Oct-28-25 11:27AM
Oct-27-25 06:27AM
Oct-24-25 05:33PM
04:55PM
12:02AM
Oct-23-25 11:40AM
Oct-22-25 09:40AM
Oct-20-25 02:03PM
Oct-17-25 06:39PM
Oct-16-25 04:32PM
Oct-08-25 12:00PM
Oct-07-25 11:31AM
Oct-06-25 11:40AM
05:15AM
Oct-01-25 08:00AM
Sep-30-25 12:00PM
Sep-24-25 12:01PM
Sep-23-25 07:10PM
06:27AM
Sep-11-25 10:57PM
Sep-08-25 03:35PM
06:27AM
Sep-03-25 02:45PM
Sep-01-25 11:31PM
Aug-27-25 12:31PM
08:00AM
Aug-26-25 06:15PM
08:00AM
Aug-14-25 01:34AM
Aug-12-25 03:25AM
Aug-08-25 06:57PM
11:53AM
Aug-07-25 02:13PM
12:23PM
09:30AM
07:35AM
06:59AM
06:27AM
Aug-06-25 06:15PM
09:15AM
Aug-05-25 11:11PM
Aug-04-25 05:45PM
Jul-31-25 01:16PM
Jul-25-25 03:36PM
Jul-24-25 05:42PM
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurzius Lawrence ErikDirectorDec 12 '25Buy21.3010,000213,000131,773Dec 16 04:42 PM
Modi Rajeev A.SEE REMARKSDec 11 '25Buy21.334,50095,985123,082Dec 15 04:43 PM
VanHimbergen Robert MEVP and CFODec 11 '25Buy21.646,950150,426124,233Dec 15 04:42 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORDec 11 '25Buy21.7522,000478,496167,000Dec 15 04:41 PM
Todd S and Jennifer G Young LiFormer CFOAug 11 '25Proposed Sale16.8249,333830,000Aug 11 03:58 PM